Broder; Cancer Act’s Special Authorities Don’t Give Director Immunity For NIH, HHS
In Brief: House, Senate Enact FY ’92 Budget Bills For NCI That Differ By $200 Million; Senate’s Is Higher
Bypass Budget Is Realistic, Defensible Plan, Broder Says
Broder On FDA: Don’t Blame Them For Doing Their Jobs (They Have To Work At Parklawn)
Tipping Resigned Forom ACS Following Volunteer Discontent
NSABP Sees Groups To Join Breast Cancer Prevention Trial
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- A new AI tool enables speedy use of ASCO guidelines, eliminating typical errors
- KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field









